In addition, the activities of a portion of the cancer immunity cycle were also found to be upregulated in the high-m6Arisk score group, including the release of cancer cell antigens (Step 1) and trafficking of immune cells to tumors (Step 4, mainly those that exert antitumor immunity), such as CD8 T cell recruiting, NK cell recruiting, and MDSC recruiting (Figure 5D, Supplementary Table S12). This evidence concerns the gene CD8A and cancer.